Skip to main content
. 2012 Feb 15;185(4):392–399. doi: 10.1164/rccm.201109-1672OC

TABLE 4.

PROPORTION OF INDIVIDUALS THAT MEET EACH OF THE CRITERIA AT MEDICAL MONITORING ENTRY

Biomarker Cases* FEV1 Less Than LLN Control Subjects* FEV1 Greater Than or Equal to LLN P Value
Metabolic syndrome 0.27 (19/71) 0.16 (26/166) 0.07
Triglycerides ≥150 mg/dl 0.51 (36/71) 0.46 (76/166) 0.57
HDL<40 mg/dl 0.32 (23/71) 0.20 (33/166) 0.05
HDL<40 and triglycerides ≥150 mg/dl 0.28 (20/71) 0.14 (23/166) 0.006
Glucose ≥100 mg/dl 0.28 (20/71) 0.16 (26/166) 0.03
Heart rate ≥66 bpm 0.65 (46/71) 0.48 (79/166) 0.02
BMI ≥30 kg/m2 0.32 (23/71) 0.26 (43/166) 0.34
Leptin ≥10,300 pg/ml§ 0.42 (30/71) 0.21 (34/166) 0.001
Pancreatic polypeptide ≤89 pg/ml 0.38 (27/71) 0.24 (40/166) 0.04
Amylin ≥116 pg/ml§ 0.07 (5/71) 0.31 (51/166) ≤0.0001

Definition of abbreviations: BMI = body mass index; HDL = high-density lipoprotein; LLN = lower limit of normal as defined by NHANES III; NHANES = National Health and Nutrition Examination Survey.

*

Proportions in group (n in group/total).

P value determined by Pearson chi-square.

National Heart Lung and Blood Institute/American Heart Association Criteria.

§

Values were represented as top quartiles.

Values were represented as bottom quartiles.